| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/ATVBAHA.109.186791 |
| P698 | PubMed publication ID | 19359660 |
| P50 | author | Angela Scipioni | Q114718773 |
| Samantha Cordone | Q114718774 | ||
| Giuseppe Pugliese | Q37382959 | ||
| Stefano Menini | Q43252011 | ||
| Carla Iacobini | Q47147866 | ||
| Flavia Pricci | Q47504388 | ||
| Giuseppe Marano | Q54230596 | ||
| Massimo Federici | Q57002627 | ||
| Matteo Serino | Q57014592 | ||
| Pier Carlo Ricci | Q60161975 | ||
| P2093 | author name string | Maurizio Taurino | |
| Viola Sansoni | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 831-836 | |
| P577 | publication date | 2009-04-09 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms | |
| P478 | volume | 29 |
| Q38317758 | Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function |
| Q28743221 | Ambient pollutants, polymorphisms associated with microRNA processing and adhesion molecules: the Normative Aging Study |
| Q36877555 | Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community |
| Q33754895 | Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment |
| Q36159048 | D-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation. |
| Q38232998 | Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis |
| Q46279581 | FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice |
| Q36025690 | Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis |
| Q90152813 | Galectin-3 Is a Potential Mediator for Atherosclerosis |
| Q28069174 | Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis |
| Q40944709 | Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets |
| Q35842591 | Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes |
| Q42624178 | Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets |
| Q36003071 | Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies |
| Q38258947 | Galectin-3: an emerging all-out player in metabolic disorders and their complications |
| Q58094533 | Galectin-3and risk of cardiovascular events and all-cause mortality in type 2 diabetes mellitus |
| Q53510307 | Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction. |
| Q58863621 | Glycoxydation promotes vascular damage Via MAPK-ERK/JNK pathways |
| Q42805774 | Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance. |
| Q34603941 | Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice |
| Q39191329 | Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice |
| Q36101077 | Lack of nitric oxide synthases increases lipoprotein immune complex deposition in the aorta and elevates plasma sphingolipid levels in lupus |
| Q34309578 | Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus |
| Q38125279 | Molecular biology of atherosclerosis |
| Q37067301 | New pathways to control inflammatory responses in adipose tissue |
| Q38705659 | Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies |
| Q89027396 | Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study |
| Q41730589 | Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice. |
| Q46298007 | Relationship of galectin-3 with obesity, IL-6, and CRP in women |
| Q37599836 | Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke |
| Q40908249 | Soluble galectin-3 is associated with premature myocardial infarction. |
| Q36844332 | Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis |
| Q33999277 | Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression |
| Q64093135 | The Role of Myeloid-Derived Cells in the Progression of Liver Disease |
| Q47703344 | The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis |
| Q28261890 | The roles of Galectin-3 in autoimmunity and tumor progression |
| Q35553234 | Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3. |
Search more.